CS
TENX icon

Credit Suisse’s Tenax Therapeutics TENX Stock Holding History

Credit Suisse’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 4282
2022
Q2 		– Hold
0
– – – 4306
2016
Q4 		– Sell
-1
Closed -$51K – 4229
2016
Q3 		$51K Hold
1
– – ﹤0.01% 4019
2016
Q2 		$57K Hold
1
– – ﹤0.01% 4141
2016
Q1 		$39K Buy
+1
New +$77.7K ﹤0.01% 3908
2015
Q4 		– Hold
0
– – – 4143
2014
Q2 		– Hold
0
– -$69K – 4798
2014
Q1 		– Hold
0
– – – 4554

Other funds holding TENX

GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's TENX Position: Q3 2022 in Review

Credit Suisse held its Tenax Therapeutics (TENX) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4282.

Credit Suisse first reported a position in TENX in Q1 2016 and has held it in 3 quarters since. The position peaked at $57K in Q2 2016. 21 funds tracked by Wall St. Rank hold TENX as of Q3 2022.

  • Credit Suisse held 0 shares of Tenax Therapeutics worth $0 as of Q3 2022.
  • Credit Suisse left its Tenax Therapeutics share count unchanged in Q3 2022.
  • Tenax Therapeutics made up ﹤0.01% of Credit Suisse's portfolio in Q3 2022, its #4282 holding.
  • Credit Suisse first reported a position in Tenax Therapeutics in Q1 2016 and has held it in 3 quarters since.
  • Credit Suisse's Tenax Therapeutics position peaked at $57K in Q2 2016.
  • 21 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.